FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics
Genocea Biosciences, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)